{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:24:44Z","timestamp":1790418284718,"version":"4.1.0"},"reference-count":58,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2001,12,25]],"date-time":"2001-12-25T00:00:00Z","timestamp":1009238400000},"content-version":"vor","delay-in-days":1242,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[1998,8]]},"abstract":"<jats:p>We determined the proportion of survival variability explained by the usual prognostic factors in childhood acute lymphoblastic leukaemia (ALL) during a prognostic study of 1552 patients enrolled in three consecutive Fralle group protocols (Fralle 83, Fralle 87 and Fralle 89). The event\u2010free survival rates at 5 years were 54.8% (SD 1.9), 43.1% (SD 2.7) and 55.6% (SD 2.2), respectively. In the univariate analysis the following variables were predictive of poor outcome: male gender, elevated leucocytosis (&gt;\u200350\u2003\u00d7\u200310<jats:sup>9<\/jats:sup>\/l), circulating blastosis, haemoglobin &gt;12\u2003g\/dl, platelet count &lt;100\u2003\u00d7\u200310<jats:sup>9<\/jats:sup>\/l, age under 1 year or over 9 years, enlarged mediastinum, nodes, spleen and liver, T phenotype, absence of CD10<jats:sup>+<\/jats:sup> cells; testicular and meningeal involvement, poor response to induction therapy (CCSG M3), and LDH &gt;400\u2003U\/l. Among the cytogenetic features, hyperdiploidy had a protective effect, whereas hypodiploidy, translocation and other structural abnormalities had a negative influence, particularly in cases of t(9;22) or t(4;11). Multivariate analysis summarized the prognostic information in terms of four variables: age, gender, leucocytosis and cytogenetic features. Missing data had little influence on the results. However, despite their significance in the multivariate analysis, these four variables each had very low predictive power (1.1% for gender, 2.0% for age, 3.5% for leucocytosis, and 1.6% for cytogenetic features). Thus, the most significant prognostic factors in childhood ALL each explain no more than 4% of the variability in prognosis. This may explain the disappointing practical value of these factors and underlines the need for prognostic tools in childhood ALL.<\/jats:p>","DOI":"10.1046\/j.1365-2141.1998.00818.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:03:20Z","timestamp":1047362600000},"page":"729-739","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: differences in outcome are poorly explained by the most significant prognostic variables"],"prefix":"10.1111","volume":"102","author":[{"given":"Jean","family":"Donadieu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie\u2010Fran\u00c7oise","family":"Auclerc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00c9","family":"Baruchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Leblanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Landman\u2010Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Perel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rard","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rard","family":"Cornu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Bordigoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Sommelet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Leverger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rard","family":"Schaison for the Fralle group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,25]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19950401)75:7<1684::AID-CNCR2820750720>3.0.CO;2-2"},{"key":"e_1_2_7_3_2","first-page":"131","article-title":"Treatment results of the EORTC\u2010Children's leukemia cooperative group (CLCG) protocols 58831\/2 in 177 children with T\u2010cell lymphoblastic leukemia or non\u2010Hodgkin lymphoma","volume":"70","author":"Bahner\u2010Ennassih E.","year":"1995","journal-title":"Annals of Hematology"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.6.1416.bloodjournal8561416"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)90164-7"},{"key":"e_1_2_7_6_2","doi-asserted-by":"crossref","unstructured":"Collet D.(1994)Modelling Survival Data in Medical Research. Chapman and Hall London.","DOI":"10.1007\/978-1-4899-3115-3"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19951215)76:12<2393::AID-CNCR2820761203>3.0.CO;2-P"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950140306"},{"key":"e_1_2_7_9_2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1182\/blood.V76.1.117.117","article-title":"Poor prognosis of children with pre\u2010B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13): Pediatric Oncology Group study","volume":"76","author":"Crist W.","year":"1990","journal-title":"Blood"},{"key":"e_1_2_7_10_2","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1182\/blood.V76.3.489.489","article-title":"Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome: Pediatric Oncology Group study","volume":"76","author":"Crist W.","year":"1990","journal-title":"Blood"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1991.tb04415.x"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V77.3.435.435"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.4.1292.bloodjournal8641292"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1990.tb02581.x"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950140305"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-74643-7_82"},{"key":"e_1_2_7_17_2","first-page":"2559","article-title":"P53 expression and poor prognosis in childhood acute lymphoblastic leukemia","volume":"14","author":"Hecker S.","year":"1994","journal-title":"Anticancer Research"},{"key":"e_1_2_7_18_2","first-page":"318","article-title":"Definition of a favorable prognostic subgroup in childhood ALL by high\u2010grade DNA aneuploidy: a BFM study group report","volume":"12","author":"Hiddeman W.","year":"1993","journal-title":"Proceedings of the American Society for Clinical Oncology"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00254045"},{"key":"e_1_2_7_20_2","first-page":"129","article-title":"Drug resistance profile: strongest independent prognostic factor in childhood leukemia in a BFM\u2010oriented treatment protocol","volume":"70","author":"Kaspers G.J.L.","year":"1995","journal-title":"Annals of Hematology"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1989.7.12.1816"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1992.tb08170.x"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V65.5.1079.1079"},{"key":"e_1_2_7_24_2","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1182\/blood.V88.11.4252.bloodjournal88114252","article-title":"TEL\/AML 1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia","volume":"88","author":"McLean T.W.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950140317"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1989.7.12.1807"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19830315)51:6<1041::AID-CNCR2820510612>3.0.CO;2-G"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/78.3.691"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-198824000-00005"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950220502"},{"key":"e_1_2_7_31_2","first-page":"375","article-title":"Adenosine deaminase and purine nucleoside phosphorylase in childhood lymphoblastic leukemia: relation with differentiation stage, in vitro drug resistance and clinical prognosis","volume":"6","author":"Pieters R.","year":"1992","journal-title":"Leukemia"},{"key":"e_1_2_7_32_2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1200\/JCO.1996.14.1.4","article-title":"Selecting treatment for children with acute lymphoblastic leukemia","volume":"14","author":"Pinkel D.","year":"1996","journal-title":"Journal of Clinial Oncology"},{"key":"e_1_2_7_33_2","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1182\/blood.V79.7.1781.1781","article-title":"Different molecular consequences of the 1;19 chromosomal translocation in childhood B\u2010cell precursor acute lymphoblastic leukemia","volume":"79","author":"Privitera E.","year":"1992","journal-title":"Blood"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V70.1.247.247"},{"key":"e_1_2_7_35_2","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1182\/blood.V77.3.440.440","article-title":"Clinical characteristics and treatment outcome of childhood lymphoblastic leukemia with t(4;11)(q21;q23): a collaborative study of 40 cases","volume":"77","author":"Pui C.H.","year":"1991","journal-title":"Blood"},{"key":"e_1_2_7_36_2","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1182\/blood.V73.7.1963.1963","article-title":"Prognostic importance of structural chomosomal abnormalities in children with hyperdiploid (>50 chromosomes) acute lymphoblastic leukemia","volume":"73","author":"Pui C.H.","year":"1989","journal-title":"Blood"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1988.6.1.56"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V79.12.3245.3245"},{"key":"e_1_2_7_39_2","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1182\/blood.V71.4.989.989","article-title":"Slow disappearance of peripheral blast cells: an independent risk factor indicating poor prognosis in children with acute lymphoblastic leukemia","volume":"71","author":"Rautonen J.","year":"1988","journal-title":"Blood"},{"key":"e_1_2_7_40_2","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1182\/blood.V84.9.3122.3122","article-title":"Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients: results and conclusions of multicenter trial ALL\u2010BFM 86","volume":"84","author":"Reiter A.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_7_41_2","first-page":"121","article-title":"Prognostic factors in childhood leukemia","volume":"7","author":"Ribeiro R.C.","year":"1993","journal-title":"Hematological Pathology"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)91615-3"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1026781"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199310283291801"},{"key":"e_1_2_7_45_2","first-page":"3","article-title":"Assessment of the interrelationship of prognostic factors in childhood acute lymphoblastic leukemia","volume":"1","author":"Robison L.","year":"1980","journal-title":"American Journal of Pediatric Hematology and Oncology"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V77.5.1050.1050"},{"key":"e_1_2_7_47_2","first-page":"87","article-title":"Presenting features and treatment outcome of adolescents with acute lymphoblastic leukemia","volume":"4","author":"Santana V.M.","year":"1990","journal-title":"Leukemia"},{"key":"e_1_2_7_48_2","first-page":"148","article-title":"Treatment of acute lymphoblastic leukemia: French protocol Fralle 83\u201387","volume":"6","author":"Schaison G.","year":"1992","journal-title":"Leukemia"},{"key":"e_1_2_7_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(96)00075-X"},{"key":"e_1_2_7_50_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(19961015)15:19<1999::AID-SIM353>3.0.CO;2-D"},{"key":"e_1_2_7_51_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.4.740"},{"key":"e_1_2_7_52_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1989.tb07713.x"},{"key":"e_1_2_7_53_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.1.18"},{"key":"e_1_2_7_54_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.2.389"},{"key":"e_1_2_7_55_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19910815)68:4<751::AID-CNCR2820680416>3.0.CO;2-T"},{"key":"e_1_2_7_56_2","first-page":"28","article-title":"Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: a report from the Children's Cancer Group","volume":"90","author":"Uckun F.M.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_7_57_2","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1182\/blood.V85.4.873.bloodjournal854873","article-title":"Leukemic cell growth in SCID mice as a predictor of relapse in high\u2010risk B\u2010lineage acute lymphoblastic leukemia","volume":"85","author":"Uckun F.M.","year":"1995","journal-title":"Blood"},{"key":"e_1_2_7_58_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.11.4288.bloodjournal88114288"},{"key":"e_1_2_7_59_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199103213241204"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.1998.00818.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.1998.00818.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.1998.00818.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T01:53:18Z","timestamp":1698457998000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.1998.00818.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,8]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998,8]]}},"alternative-id":["10.1046\/j.1365-2141.1998.00818.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.1998.00818.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,8]]},"assertion":[{"value":"2001-12-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}